Long-term blockade of the expression of cocaine sensitization by ondansetron, a 5-HT3 receptor antagonist

被引:64
作者
King, GR [1 ]
Xiong, ZP [1 ]
Douglass, S [1 ]
Ellinwood, EH [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA
关键词
5-HT3; receptor; cocaine; ondansetron; sensitization; (rat);
D O I
10.1016/S0014-2999(99)00926-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Intermittent cocaine administration induces sensitization (reverse tolerance) to its behavioral effects. The mechanism(s) mediating sensitization is not clear, however, previous research has implicated 5-HT3 receptors in the expression of sensitization. The present experiment evaluated the ability of the 5-HT3 receptor antagonist, ondansetron, administered during withdrawal from chronic intermittent cocaine administration, to block the expression of sensitization. Rats were pretreated for 14 days by daily subcutaneous injections of either 40 mg/kg cocaine or 0.9% saline. During the first 5 days of withdrawal from this pretreatment regimen, all rats received a daily subcutaneous injection of 0-1.0 mg/kg ondansetron. On days 7, 14 or 28 of withdrawal from the cocaine pretreatment, the rats received a 15.0-mg/kg cocaine challenge. Ambulatory behavior was automatically recorded for 60 min. Ondansetron had no significant effect on the subsequent behavioral response to cocaine in the saline control subjects. In contrast, daily injections of ondansetron blocked the expression of sensitization at all withdrawal times. We thus report that it is possible to permanently block the expression of sensitization once it has developed by administering a 5-HT3 receptor antagonist. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:97 / 101
页数:5
相关论文
共 50 条
  • [41] EFFECT OF ONDANSETRON, A 5-HT3 ANTAGONIST, ON COPPER SULFATE-INDUCED EMESIS IN THE FERRET
    ENDO, T
    MINAMI, M
    MONMA, Y
    YOSHIOKA, M
    SAITO, H
    TOSHIMITSU, Y
    PARVEZ, SH
    BIOGENIC AMINES, 1991, 8 (02) : 79 - 86
  • [42] Downregulated hypothalamic 5-HT3 receptor expression and enhanced 5-HT3 receptor antagonist-mediated improvement in fatigue-like behaviour in cholestatic rats
    Nguyen, H.
    Wang, H.
    Le, T.
    Ho, W.
    Sharkey, K. A.
    Swain, M. G.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2008, 20 (03) : 228 - 235
  • [43] Demonstration of 5-HT3 receptor function and expression in the mouse bladder
    N. Chetty
    I. M. Coupar
    R. Chess-Williams
    K. P. Kerr
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2007, 375 : 359 - 368
  • [44] Cocaine inhibits 5-HT3 receptor function in neurons from transgenic mice overexpressing the receptor
    Carta, M
    Allan, AM
    Partridge, LD
    Valenzuela, CF
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 459 (2-3) : 167 - 169
  • [45] Deletion of the 5-HT3A-receptor subunit blunts the induction of cocaine sensitization
    Hodge, C. W.
    Bratt, A. M.
    Kelley, S. P.
    GENES BRAIN AND BEHAVIOR, 2008, 7 (01) : 96 - 102
  • [46] 5-HT3 receptor antagonism and psychoactivity
    Sullivan, JT
    Preston, KL
    Testa, MP
    Bell, J
    Jasinski, DR
    JOURNAL OF PSYCHOPHARMACOLOGY, 1996, 10 (03) : 182 - 187
  • [47] EFFECTS OF THE 5-HT3 ANTAGONIST ONDANSETRON ON BENZODIAZEPINE-INDUCED OPERANT BEHAVIORAL DEPENDENCE IN RATS
    GOUDIE, AJ
    LEATHLEY, MJ
    PSYCHOPHARMACOLOGY, 1992, 109 (04) : 461 - 465
  • [48] EFFECT OF COCAINE ON THE 5-HT3 RECEPTOR-MEDIATED ION CURRENT IN XENOPUS OOCYTES
    FAN, P
    OZ, M
    ZHANG, L
    WEIGHT, FF
    BRAIN RESEARCH, 1995, 673 (02) : 181 - 184
  • [49] THE EFFECT OF A 5-HT3 RECEPTOR ANTAGONIST, ONDANSETRON, ON BRAIN-STIMULATION REWARD, AND ITS INTERACTION WITH DIRECT AND INDIRECT STIMULANTS OF CENTRAL DOPAMINERGIC TRANSMISSION
    MONTGOMERY, AMJ
    ROSE, IC
    HERBERG, LJ
    JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1993, 91 (01) : 1 - 11
  • [50] 5-HT3 ANTAGONIST ONDANSETRON FOR THE TREATMENT OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN AN OUTPATIENT POPULATION
    CASPER, J
    CASPER, S
    KOHNEWOMPNER, CH
    BOKEMEYER, C
    HECKER, H
    SCHMOLL, HJ
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1994, 4 (06) : 1283 - 1289